Furthermore, the protein and mRNA levels of AR were slightly elevated in resistant PCa (Fig. 2C and D), consistent with the results of our GEO database screening, which indicated that additional transcriptional mechanisms leading to elevation of ABCC5 level and activation of downstream pathways possibly contributed to the acquisition of enzalutamide resistance. This evidence concerns the gene AR and posterior cortical atrophy.